News

Astellas Pharma’ FAMOUS trial, in which Gaster (famotidine) was effective on the prevention of peptic ulcers in uses of low-dose aspirin, was observed and reported in the medical

Security experts from the FBI, DHS and the private sector emphasized believe that importance of awareness in preventing the theft and diversion of chemicals is inevitable. According to

Staff from the US Senate Homeland Security and Governmental Affairs Committee warned summit attendees that legislation to make permanent chemical site security rules was unlikely to pass this

Amarin has reached an agreement with the FDA under a Special Protocol Assessment (SPA), for its planned phase-III clinical trial of AMR101 (ethyl-EPA) in patients with mixed dyslipidemia.

AstraZeneca has terminated the license agreement with MAP Pharmaceuticals, regarding Unit Dose Budesonide (UDB). UDB, an investigational treatment for paediatric asthma, was the subject of an initial phase-III

The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline’ (GSK) cervical cancer vaccine. GSK filed Cervarix for WHO prequalification in September 2007, less than one week

Dow Basic Plastics Licensing and Catalyst (Dow) has increased the capacity at its SHAC Catalyst plant in Norco by 20%. The SHAC Catalysts are used in the production

Spectrum Pharmaceuticals has submitted a formal response to the Complete Response Letter it received from the FDA. It was regarding its supplemental Biologics License Application (sBLA) for ZEVALIN

Life Sciences Research (LSR) has entered into a merger agreement to be acquired by Lion Holdings, for $8.50 per share in cash. Under the terms of the agreement,